The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid

BACKGROUND: Despite the effectiveness of currently available antiretroviral therapies in the treatment of HIV-1 infection, a continuing need exists for novel compounds that can be used in combination with existing drugs to slow the emergence of drug-resistant viruses. We previously reported that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jing, Chen, Chin Ho, Aiken, Christopher
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC479704/
https://www.ncbi.nlm.nih.gov/pubmed/15225375
http://dx.doi.org/10.1186/1742-4690-1-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC479704/
https://www.ncbi.nlm.nih.gov/pubmed/15225375
http://dx.doi.org/10.1186/1742-4690-1-15

Ejemplares similares